Learning from the “tail end” of de-implementation: the case of chemical castration for localized prostate cancer

BACKGROUND: Men with prostate cancer are often treated with the suppression of testosterone through long-acting injectable drugs termed chemical castration or androgen deprivation therapy (ADT). In most cases, ADT is not an appropriate treatment for localized prostate cancer, indicating low-value ca...

Descripción completa

Detalles Bibliográficos
Autores principales: Skolarus, Ted A., Forman, Jane, Sparks, Jordan B., Metreger, Tabitha, Hawley, Sarah T., Caram, Megan V., Dossett, Lesly, Paniagua-Cruz, Alan, Makarov, Danil V., Leppert, John T., Shelton, Jeremy B., Stensland, Kristian D., Hollenbeck, Brent K., Shahinian, Vahakn, Sales, Anne E., Wittmann, Daniela A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555144/
https://www.ncbi.nlm.nih.gov/pubmed/34711274
http://dx.doi.org/10.1186/s43058-021-00224-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8555144/
https://www.ncbi.nlm.nih.gov/pubmed/34711274
http://dx.doi.org/10.1186/s43058-021-00224-8

Ejemplares similares